Mus vs Sao Tome and Principe: Treatment success rate for patients treated for MDR-TB
Mus
100.0%
in 2022
Sao Tome and Principe
100.0%
in 2022
Mus rank
1st
Sao Tome and Principe rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Mus
- Sao Tome and Principe
How they compare
Mus currently reports 100.0% against 100.0% in Sao Tome and Principe, a difference of 0.0%.
The two have swapped places 4 times across 7 shared years of data; in 2011 it was Sao Tome and Principe ahead.
Mus ranks 1st and Sao Tome and Principe ranks 1st of 1 regions.
Sao Tome and Principe has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mus | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 73.4% | 76.0% | 2.6% | Sao Tome and Principe |
| 2020s | 75.0% | 83.5% | 8.5% | Sao Tome and Principe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Mus or Sao Tome and Principe?
- Mus, at 100.0% against 100.0% in Sao Tome and Principe as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Mus and Sao Tome and Principe?
- 0.0%, with Mus ahead.
- How many years of comparable data are there for Mus and Sao Tome and Principe?
- 7 years are reported by both, from 2011 to 2022.
- How do Mus and Sao Tome and Principe rank globally for treatment success rate for patients treated for mdr-tb?
- Mus ranks 1st and Sao Tome and Principe ranks 1st of 1 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.